Redwoods Acquisition Corp. Files 8-K on Shareholder Votes
Ticker: GRMLW · Form: 8-K · Filed: Apr 18, 2024 · CIK: 1907223
| Field | Detail |
|---|---|
| Company | Redwoods Acquisition CORP. (GRMLW) |
| Form Type | 8-K |
| Filed Date | Apr 18, 2024 |
| Risk Level | low |
| Pages | 7 |
| Reading Time | 8 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, regulation-fd, filing
TL;DR
Redwoods Acquisition Corp. held a shareholder vote on April 12th, details to follow.
AI Summary
Redwoods Acquisition Corp. filed an 8-K on April 18, 2024, reporting on matters submitted to a vote of security holders and a Regulation FD disclosure. The filing date for the earliest event reported was April 12, 2024. The company is incorporated in Delaware and its principal executive offices are located in New York, NY.
Why It Matters
This filing indicates that Redwoods Acquisition Corp. has held or is holding a vote of its security holders, which could lead to significant corporate actions or changes.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting a shareholder vote and Regulation FD disclosure, with no immediate negative financial implications apparent.
Key Players & Entities
- Redwoods Acquisition Corp. (company) — Registrant
- April 12, 2024 (date) — Date of earliest event reported
- April 18, 2024 (date) — Filing date
- New York, NY (location) — Principal executive offices location
FAQ
What specific matters were submitted to a vote of Redwoods Acquisition Corp. security holders?
The filing indicates that matters were submitted to a vote, but the specific details of these matters are not provided in the provided text.
What is the nature of the Regulation FD disclosure made by Redwoods Acquisition Corp.?
The filing states that a Regulation FD disclosure was made, but the content of this disclosure is not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on April 12, 2024.
Where are the principal executive offices of Redwoods Acquisition Corp. located?
The principal executive offices are located at 1115 Broadway, 12th Floor, New York, NY 10010.
What is the SIC code for Redwoods Acquisition Corp.?
The Standard Industrial Classification (SIC) code for Redwoods Acquisition Corp. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Stats: 2,077 words · 8 min read · ~7 pages · Grade level 15.3 · Accepted 2024-04-18 17:23:20
Filing Documents
- ea0204215-8k425_redwoods.htm (8-K) — 71KB
- 0001213900-24-034182.txt ( ) — 300KB
- rwod-20240412.xsd (EX-101.SCH) — 4KB
- rwod-20240412_def.xml (EX-101.DEF) — 27KB
- rwod-20240412_lab.xml (EX-101.LAB) — 37KB
- rwod-20240412_pre.xml (EX-101.PRE) — 25KB
- ea0204215-8k425_redwoods_htm.xml (XML) — 7KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 12, 2024 Redwoods Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-41340 86-2727441 (Commission File Number) (IRS Employer Identification No.) 1115 Broadway , 12th Floor New York , NY 10010 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code ( 646 ) 916-5315 (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Units, RWODU The Nasdaq Stock Market LLC Common Stock RWOD The Nasdaq Stock Market LLC Warrants RWODW The Nasdaq Stock Market LLC Rights RWODR The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.07. Submissions of Matters to a Vote of Security Holders. On May 30, 2023, Redwoods Acquisition Corp. ("Redwoods") entered into a business combination agreement, as amended pursuant to Amendment No. 1 thereto dated as of November 4, 2023 (as the same has been or may be amended, modified, supplemented or waived from time to time, the " Business Combination Agreement "), by and among Redwoods, Anew Medical Sub, Inc., a Wyoming corporation and direct, wholly owned subsidiary of Redwoods (" Merger Sub "), and ANEW MEDICAL, INC., a Wyoming corporation (the " ANEW "), which, among other things, provides for the merger of Merger Sub with and into ANEW, with ANEW surviving such merger as a wholly owned subsidiary of Redwoods (the " Transactions "). Following the consummation of the Transactions, Redwoods will change its name to ANEW MEDICAL, INC. On April 12, 2024 at 10:00 a.m. EST, Redwoods held a special meeting of stockholders (the " Meeting ") at which the Company's stockholders voted on the following proposals, as set forth below, each of which is described in detail in the definitive proxy statement (the " Proxy Statement ") filed with the Securities and Exchange Commission (the " SEC ") on February 20, 2024, which was first mailed by the Company to its shareholders on or about February 20, 2024. As February 16, 2024, the record date for the Meeting, there were 5,165,194 shares of common stock issued and outstanding and entitled to vote. There were 4,189,027 shares of common stock represented in person or by proxy at the Meeting. The final voting results for each proposal submitted to the stockholders of Redwoods at the Meeting are included below. Each of the proposals described below was approved by Redwoods's stockholders. Matter For Against Abstain Proposal 1 - A proposal to approve the business combination, including (a) adopting the Business Combination Agreement and (b) approving the other transactions contemplated by the Business Combination Agreement and related agreements. 4,185,975 3,052 0 Proposal 2- A proposal to approve and adopt the second amended and restated certificate of incorporation. 4,135,672 53,355 0 Proposal 3- A proposal to approve, on a non-binding advisory basis, certain governance provisions in the second amended and restated certificate of incorporation, presented separately in accordance with the United States Securities and Exchange Commission ("SEC") requirements 4,135,672 53,355 0 Proposal 4- A proposal to adopt the ANEW MEDICAL, INC. 2023 Stock Incentive Plan, and the material terms thereof, including the authorization of the initial share reserve thereunder. 4,135,672 53,355 0 Proposal 5- A proposal to elect five directors to serve on the combined company's board of directors effective as of the closing of the transactions in accordance